Case Series of 6 Fetuses With Osteogenesis Imperfecta Type II: A Retrospective Study of Heart Pathology.

COL1A1 COL1A2 OI type II collagen type I heart pathology osteogenesis imperfecta

Journal

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
ISSN: 1615-5742
Titre abrégé: Pediatr Dev Pathol
Pays: United States
ID NLM: 9809673

Informations de publication

Date de publication:
27 Aug 2024
Historique:
medline: 27 8 2024
pubmed: 27 8 2024
entrez: 27 8 2024
Statut: aheadofprint

Résumé

Osteogenesis imperfecta (OI) is a rare genetic disorder characterized by bone fragility. While skeletal manifestations are well documented, few studies have explored the effect of OI on the fetal heart. This retrospective case series investigates cardiac pathology in OI type II fetuses, aiming to address this gap. Medical records and autopsy reports of 6 genetically confirmed OI type II cases were examined. Fetuses had pathogenic variants in Immunohistochemistry confirmed robust expression of collagen type I throughout the heart. Five fetuses had normal heart weight, while 1 had a low heart weight in the context of generalized growth retardation. None displayed structural heart anomalies. This study reveals robust collagen type I expression in the hearts of OI type II fetuses without structural anomalies. We hypothesize that collagen type I abnormalities may not be causative factors for heart anomalies during early embryonic development. Instead, their impact may be conceivably related to an increased susceptibility to degenerative changes later in life.

Identifiants

pubmed: 39189102
doi: 10.1177/10935266241272511
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

10935266241272511

Déclaration de conflit d'intérêts

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Sara J E Verdonk (SJE)

Department of Endocrinology and Metabolism, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Rare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Amsterdam Movement Sciences, Amsterdam, The Netherlands.

Silvia Storoni (S)

Department of Endocrinology and Metabolism, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Rare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Amsterdam Movement Sciences, Amsterdam, The Netherlands.

Lidiia Zhytnik (L)

Rare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Amsterdam Movement Sciences, Amsterdam, The Netherlands.
Department of Human Genetics, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, The Netherlands.
Department of Traumatology and Orthopaedics, The University of Tartu, Tartu, Estonia.
Amsterdam Reproduction and Development, Amsterdam, The Netherlands.

Dimitra Micha (D)

Rare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Amsterdam Movement Sciences, Amsterdam, The Netherlands.
Department of Human Genetics, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, The Netherlands.
Amsterdam Reproduction and Development, Amsterdam, The Netherlands.

Joost G van den Aardweg (JG)

Department of Respiratory Medicine, Amsterdam University Medical Center, Academic Medical Center, Amsterdam, The Netherlands.

Otto Kamp (O)

Department of Cardiology, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam, The Netherlands.

Elisabeth M W Eekhoff (EMW)

Department of Endocrinology and Metabolism, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Rare Bone Disease Center Amsterdam, Amsterdam, The Netherlands.
Amsterdam Movement Sciences, Amsterdam, The Netherlands.
Amsterdam Reproduction and Development, Amsterdam, The Netherlands.

Marianna Bugiani (M)

Department of Pathology, Amsterdam University Medical Center, Academic Medical Center, Amsterdam, The Netherlands.

Classifications MeSH